Back to Journals » Patient Preference and Adherence » Volume 5

Hyaluronic acid dermal fillers: can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration?

Authors Smith, Cockerham K

Published 14 March 2011 Volume 2011:5 Pages 133—139

DOI https://doi.org/10.2147/PPA.S11251

Review by Single-blind

Peer reviewer comments 4

Lynnelle Smith1, Kimberly Cockerham2
1Ophthalmology Department, Loma Linda University, Loma Linda, CA, USA; 2Ophthalmology Department, Stanford University, Palo Alto, CA, USA

Abstract: Hyaluronic acid (HA) dermal fillers are the most widely used injectables to augment facial volume without surgery. HA dermal fillers are popular because of their ease of administration, predictable effectiveness, good safety profile, and quick patient recovery. The most common patient complaint is pain. Our goal is to review the current literature on HA fillers and compare outcomes with and without lidocaine. We found adjunctive lidocaine significantly decreases pain during injection and postinjection with corresponding increased patient satisfaction. The efficacy and safety profile appears unchanged. Rare complications with HA fillers and those associated with constituents of the product, contaminants, and lidocaine are reviewed. The corrective effects of HA fillers are temporary; repeat treatment is required to maintain results. Minimizing pain is crucial to optimize patient satisfaction.
Keywords: hyaluronic acid, lidocaine, drug toxicity, hypersensitivity, collagen, herpes simplex

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]